Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1186/1756-9966-28-18.pdf
Reference32 articles.
1. Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, et al: Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000, 88: 358-363. 10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O.
2. Gretschel S, Siegel R, Estevez-Schwarz L, Hunerbein M, Schneider U, Schlag PM: Surgical strategies for gastric cancer with synchronous peritoneal carcinomatosis. Br J Surg. 2006, 93: 1530-1535. 10.1002/bjs.5513.
3. Brenner DE: Intraperitoneal chemotherapy: a review. J Clin Oncol. 1986, 4: 1135-1147.
4. Pilati P, Rossi CR, Mocellin S, Foletto M, Scagnet B, Pasetto L, et al: Multimodal treatment of peritoneal carcinomatosis and sarcomatosis. Eur J Surg Oncol. 2001, 27: 125-134. 10.1053/ejso.2000.1021.
5. Sugarbaker PH: Peritonectomy procedures. Ann Surg. 1995, 221: 29-42.
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Intra-pleural and intra-peritoneal tocilizumab therapy for managing malignant pleural effusions and ascites: The Regional Immuno-Oncology Trial (RIOT)−2 study protocol;Surgical Oncology Insight;2024-06
2. Phase 1b study of intraperitoneal ipilimumab and nivolumab in patients with recurrent gynecologic malignancies with peritoneal carcinomatosis;Med;2024-04
3. Immunotherapy for Peritoneal Carcinomatosis: Challenges and Prospective Outcomes;Cancers;2023-04-20
4. Current Trends in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Disease from Appendiceal and Colorectal Malignancies;Journal of Clinical Medicine;2022-05-18
5. Immune response and locoregional treatments for peritoneal carcinomatosis;International Review of Cell and Molecular Biology;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3